IGF2 and cancer: Thus, we could hypothesize that a CN gain at this locus could be an early alteration in a multi-step tumor progression (already present in benign tumors), while the following loss of an allele leading to a cnLOH could represent a second hit, leading to the increased IGF2 expression only in malignant tumors.